Completely natural, free of phytocannabinoids and with no intoxicating properties, our unique ECSentials™ formulas are made with proprietary blends of natural terpenes sourced from non-cannabis-derived botanicals.
Essential Oils Formula
This unique concept features a proprietary blend of select terpenes and essential oils, including Lavandula augustifolia, Mentha piperita and Mentha spicata, reported to support digestive health and provide calmative effects.1 3 The Essential Oils Formula is provided in a base formulation that has been reported to promote skin penetration.1 4 Available in roll-on, spray bottle or glass dropper with spout.
Pure Terpenes Formula
Wellness Dietary Supplement Formula
Certified-organic hemp seed oil, our patented source of omega-3 fatty acids, MaxSimil® fish oil, and proprietary blends of terpenes sourced from non-cannabis-derived botanicals combine to support the endocannabinoid system and help maintain general health 1 in the convenient form of a dietary supplement.
The Endocannabinoid System (ECS)
The ECS helps maintain health and well-being. It is responsible for modulating the body’s immune system, inflammation, pain, and elements that affect daily life such as sleep, appetite and mood. 6 Endocannabinoids, which are neuromodulators, lock into existing receptors called cannabinoid receptors, CB1 and CB2, which sit on the surface of many cells. 7 The ECS is the body’s regulator of homeostasis, a dynamic state of equilibrium that works to keep the body functioning optimally. Contact our sales team for details at [email protected]
- 1. These statements have not been evaluated by the Food and Drug Administration (FDA). These products are not intended to diagnose, treat, cure or prevent any disease.
- 2. Gertsch, J., et al. 2008. Proceedings of the National Academy of Sciences, 105(26), pp.9099-9104.
- 3. Natural Health Product Aromatherapy – Essential Oils Monograph. December 8, 2015. Health Canada.
- 4. Herman, A. and Herman, A.P., 2015. Journal of Pharmacy and Pharmacology, 67(4), pp.473-485.
- 5. Klauke, A.L., et al. 2014. European Neuropsychopharmacology, 24(4), pp.608-620.
- 6. Sallaberry, C.A. and Astern, L., 2018. Journal of Young Investigators, 34(6).
- 7. Battista, N., et al. 2012. Frontiers in behavioral neuroscience, 6, p.9.